To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Division Vote (Commons)
15 May 2024 - Criminal Justice Bill - View Vote Context
Mark Pritchard (Con) voted No - in line with the party majority and in line with the House
One of 272 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 167 Noes - 275
Division Vote (Commons)
15 May 2024 - Criminal Justice Bill - View Vote Context
Mark Pritchard (Con) voted No - in line with the party majority and in line with the House
One of 268 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 171 Noes - 272
Division Vote (Commons)
15 May 2024 - Criminal Justice Bill - View Vote Context
Mark Pritchard (Con) voted No - in line with the party majority and in line with the House
One of 260 Conservative No votes vs 1 Conservative Aye votes
Vote Tally: Ayes - 17 Noes - 268
Speech in Commons Chamber - Wed 15 May 2024
Ukraine and Georgia

Speech Link

View all Mark Pritchard (Con - The Wrekin) contributions to the debate on: Ukraine and Georgia
Written Question
Ritlecitinib: Shropshire
Tuesday 14th May 2024

Asked by: Mark Pritchard (Conservative - The Wrekin)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when she expects Litfulo to be made available to NHS patients in (a) Shropshire, (b) Telford and (c) Wrekin.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.

On 27 March 2024, NICE published final technology appraisal guidance recommending ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years old and over. The NHS in England is legally required to fund medicines recommended by NICE within three months of the publication of its final guidance.

MP Financial Interest
Mark Pritchard (Conservative - The Wrekin)
Original Source (13th May 2024)
1. Employment and earnings
Role, work or services: Marketing advice
Payer: Redway AG (An engineering and technical services company and a client of MAP Advisory Ltd.), Oberer Graben 4-6, 9001, St Gallen, Switzerland
(Registered 17 January 2024)
Division Vote (Commons)
30 Apr 2024 - Digital Markets, Competition and Consumers Bill - View Vote Context
Mark Pritchard (Con) voted Aye - in line with the party majority and in line with the House
One of 263 Conservative Aye votes vs 1 Conservative No votes
Vote Tally: Ayes - 273 Noes - 163
Division Vote (Commons)
30 Apr 2024 - Digital Markets, Competition and Consumers Bill - View Vote Context
Mark Pritchard (Con) voted Aye - in line with the party majority and in line with the House
One of 264 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 272 Noes - 162
Division Vote (Commons)
30 Apr 2024 - Digital Markets, Competition and Consumers Bill - View Vote Context
Mark Pritchard (Con) voted Aye - in line with the party majority and in line with the House
One of 267 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 274 Noes - 162
Division Vote (Commons)
30 Apr 2024 - Digital Markets, Competition and Consumers Bill - View Vote Context
Mark Pritchard (Con) voted Aye - in line with the party majority and in line with the House
One of 266 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 276 Noes - 161